A deep dive on Steve Jurvetson and Maryanna Saenko's $200 million new fund

But she also said she could “not think of a single situation where we’re not fully in the information flow of the company” even without a director role, which is often why VCs insist on one.In the meantime, well beyond its Musk-related bets, Future has been assembling a portfolio that’s wide-ranging, with investments tied to cellular manufacturing, longevity, and edge AI, among other things.It just led a follow-on round in Sensei Biotherapeutics, a 21-year-old, Boston-based developer of personalized cancer drugs that’s planning a public offering this year and which uses bacteriophage to induce an adaptive immune response.Future — which is also investor in the lab-grown meat producer Memphis Meats — is also very focused right now on regenerative agriculture and permaculture, which is an approach to land management that adopts arrangements observed in flourishing natural ecosystems.Said Saenko, “I think it would behoove all of us to look at our food industry and ask what are the ways in which we are currently feeding our global population that are unsustainable in the future, given the number of people that we have and are going to continue having on this planet.”What doesn’t interest the pair remotely are other trends sweeping the venture industry right now, from space investing to moving from California.On space investing, Jurvetson — who led DFJ’s investment in both SpaceX and the satellite company Planet — said it’s far too crowded now (“though I’m going to be a space tourist one day for sure”).As for moving — as Musk did recently to Austin — Saenko isn’t going anywhere, she said.